跳至主要内容
临床试验/NCT03173287
NCT03173287Unknown不适用

Quantification of Hepatic Fibrosis by IVIM Sequences in 1.5T MRI.

University Hospital, Clermont-Ferrand2 个研究点 分布在 1 个国家目标入组 63 人开始时间: 2017年3月1日最近更新:
适应症

试验速览

阶段
不适用
发起方
入组人数
63
试验地点
2
主要终点
Measured perfusion-related scattering value

研究概览

简要总结

Quantification of hepatic fibrosis by IVIM sequences in 1.5T MRI.

详细描述

Early and accurate diagnosis of hepatic fibrosis in patients with chronic liver disease is essential and essential. This assessment could be performed by a non-invasive MRI method.

The main objective of this study is to show that the measured perfusion-related scattering value (D *) is related to the hepatic fibrosis stage.

Secondary objectives

  • Evaluation of infusion fraction (f) and fibrosis stage.
  • Evaluation of molecular diffusion (D) and fibrosis stage.
  • Evaluation of ADC and fibrosis stage.
  • Assess whether there is a link between the etiology of fibrosis and the value of the diffusion.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Diagnostic
盲法
None

盲法说明

Open

入排标准

年龄范围
18 Years 至 100 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients undergoing hepatic biopsy (trans-parietal or trans-jugular) in the context of liver disease
  • Signature of written consent

排除标准

  • Contra-indications to MRI
  • Refusal of protocol
  • Underage patients and protected adults

结局指标

主要结局

Measured perfusion-related scattering value

时间窗: at day 1

The main objective of this study is to show that the measured perfusion-related scattering value (D \*) is related to the hepatic fibrosis stage.

次要结局

  • Measured perfusion-related of infusion fraction(at day 1)
  • Measured perfusion-related of ADC(at day 1)
  • Measured perfusion-related of molecular diffusion(at day 1)

研究者

发起方
University Hospital, Clermont-Ferrand
申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验